Summary
Canine mammary tumors (CMTs) have been proposed to be a good animal model for human breast cancer. To provide a basis for the tumorigenic study of CMTs, cell lines were established using a modified cell culture technique. The epithelial morphology and immunostaining with cytokeratin 18 confirmed the epithelial origin of the cells. In an investigation of possible mammary tumorigenesis-related factors, the expression of Wnt signaling-related proteins was detected in cell lines. Secreted frizzled-related protein 2 (SFRP2) was abundantly expressed in CMT cells but not in normal canine mammary gland (MG) cells. Secrted frizzled-related protein 2 was secreted into the culture medium and was associated with the extracellular matrix. In addition, increased expressions of β-catenin and cyclin D1 were observed in cells overexpressing SFRP2. The marked differential expression of SFRP2 reveals that this protein may be a potential candidate marker for CMTs. The CMT cell line established in this study provides a useful tool and experimental model for understanding both the tumorigenesis of CMTs and the role of Wnt signaling in cancers.
Similar content being viewed by others
References
Andreasen, C. B.; Mahaffey, E. A.; Duncan, J. R. Intermediate filament staining in the cytologic and histologic diagnosis of canine skin and soft tissue tumors. Vet. Pathol. 25:343–349; 1998.
Bafico, A.; Gazit, A.; Pramila, T.; Finch, P. W.; Yaniv, A.; Aaronson, S. A. Interaction of Frizzled related protein (FRP) with Wnt ligands and the Frizzled receptor suggests alternative mechanisms for RFP inhibition of Wnt signaling. J. Biol. Chem. 274:16180–16187; 1999.
Bergstein, I.; Brown, A. M. C. Breast cancer. In: Bow-cock, A. M., ed. Molecular genetics, pathogenesis and therapeutics. Totowa, NJ: Human Press; 1999;181–198.
Bradley, R. S.; Brown, A. M. The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix. EMBO J. 9:1569–1575; 1990.
Chang, C. J.; Chen, Y. L.; Lee, S. C. Coactivator TIFI interacts with transcription factor C/EBP and glucocorticoid receptor to induce I-Acid glycoprotein gene expression. Mol. Cell. Biol. 18:5880–5887; 1998.
Chrisp, C. E.; Spangler, W. L. The malignant canine mammary tumor as a model for the study of human breast cancer. In: Shifrine, M., ed. The canine as a biomedical research model. Washington, DC, US Department of Energy, Technical Information Center, 1980:331–349.
Dendy, P. P. Methodology for human tumor biopsy specimens. In: Dendy, P. P., ed. Human tumors in short term culture. Techniques and clinical applications. Academic Press: Philadelphia, W. B. Saunders; 1976; 1–64.
Destexhe, E.; Lespagnard, L.; Degeyter, M.; Heymann, R.; Coignoul, F. Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in caninc mammary tumors. Vet. Pathol. 30:146–154; 1993.
Donnay, I.; Rauis, J.; Devleeschouwer, N.; Wouters-Ballman, P.; Leclercq, G.; Verstegen, J. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs. Am. J. Vet. Res. 56:1188–1194; 1995.
Donnay, I.; Rauis, J.; Wouters-Ballman, P.; Devleeschouwer, N.; Leclercq, G.; Verstegen, J. P. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. J. Reprod. Fertil. 47:501–512; 1993.
Finch, P. W.; He, X.; Kelley, M. J., et al. Purification and molecular cloning of a secreted, frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. USA 94:6770–6775; 1997.
Fowler, E. H.; Wilson, G. P.; Koeser, A. Biologic behavior of canine mammary neoplasms based on a histogenic classification. Vet. Pathol. 11:212–229; 1974.
Frisch, S. M.; Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell. Biol. 124:619–626; 1994.
Fuentealba, I. C.; Mullins, J. E. Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumors. Histol. Histopathol. 14:51–61; 1999.
Grown, A. M.; Vogel, A. M. Monoclonal antibodies to human intermediate filament proteins. Am. J. Clin. Pathol. 84:413–424; 1985.
Hood, C. J.; Parham, D. M. A simple method of tumor culture. Pathol. Res. Pract. 194:177–181; 1998.
Huelsken, J.; Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11:547–553; 2001.
Ingvarsson, S. Molecular genetics of breast cancer progression. Semin. Cancer Biol. 9:277–288; 1999.
Jones, S. E.; Jomary, C. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 24:811–820; 2002.
Lin, C. T.; Sargan, D. R. Generation and analysis of canine retinal ESTs: isolation and expression of retina-specific gene transcripts. Biochem. Biophys. Res. Commun. 282:394–403; 2001.
Lin, S. Y.; Xia, W.; Wang, J. C.; Kwong, K. Y.; Spohn, B.; Wen, Y.; Pestell, R. G.; Hung, M. C. β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA 97:4262–4266; 2000.
Lin, W. C.; Shen, B. J.; Tsay, Y. G.; Yen, H. C.; Lee, S. C.; Chang, C. J. Transcriptional activation of C/EBPbeta gene by c-Jun and ATF2. DNA Cell Biol. 21:551–560; 2002.
MacEwen, E. G.; Withrow, S. J. Tumors of the mammary gland. In: Withrow, S. J.; MacEwen, E. G., ed. Small animal clinical oncology. Philadelphia, PA: W. B. Saunders; 1996:356–372.
Martin, P. M.; Cotard, M.; Mialot, J. P.; Andre, F.; Andre, F.; Raynaud, J. P. Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother. Pharmacol. 12:13–17; 1984.
Melkonyan, H. S.; Chang, W. C.; Shapiro, J. P. SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. USA 94:13636–13641; 1997.
Meredith, J. E., Jr.; Fazeli, B.; Schwartz, M. A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4:953–961; 1993.
Middleton, L. P.; Chen, V.; Perkins, G. H.; Pinn, V.; Page, D. Histopathology of breast cancer among African American women. Cancer 97 (Suppl. 1):253–257; 2003.
Moore, A. S.; Madewell, B. R.; Lund, J. K. Immunohistochemical evaluation of intermediate filament expression in feline neoplasms. Am. J. Vet. Res. 50:88–92; 1989.
Morin P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutation in β-catenin or APC. Science 275:1787–1790; 1997.
Nerurkar, V. R.; Chitale, B. V.; Jalnapurkar, B. V.; Naik, S. N.; Lalitha, V. S. Comparative pathology of canine mammary tumors. J. Comp. Pathol. 101:389–397; 1989.
Newcomer, L. M.; Newcomb, P. A.; Trentham-Dietz, A.; Storer, B. E.; Yasui, Y.; Daling, J. R.; Potter, J. D. Detection method and breast carcinoma histology. Cancer 95:470–477; 2002.
Papkoff, J. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J. Biol. Chem. 272:4536–4543; 1997.
Papkoff, J.; Schryver, B. Secreted int-1 protein is associated with the cell surface. Mol. Cell. Biol. 10:2723–2730; 1990.
Pierrepoint, C. G. Possible benefits to veterinary medicine of considering the dog as a model for human cancer. J. Small Anim. Pract. 26:43–47; 1985.
Polakis, P. Wnt signaling and cancer. Genes Dev. 14:1837–1851; 2000.
Re, F.; Zanetti, A.; Sironi, M.; Polentarutti, N.; Lanfrancone, L.; Dejana, E. Colotta, F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127:537–546; 1994.
Ross, J. S.; Fletcher, J. A. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am. J. Clin. Pathol. 112:S53-S67; 1999.
Schleger, C.; Heck, R.; Niketeghad, F., et al. Establishment and characterization of a non-tumorigenic cells line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. Exp. Cell Res. 236:418–426; 1997.
Schneider, R. Comparison of age, sex and incidence rates in human and canine breast cancer. Cancer 26:419–426; 1970.
Schumann, H.; Holtz, J.; Zerkowski, H. R.; Hatzfeld, M. Expression of secreted frizzled related protein 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. Cardiovasc. Res. 45:720–728; 2000.
Simpson, J. F.; Page, D. L. The p53 tumor suppressor gene in ductal carcinoma in situ of the breast. Am. J. Pathol. 156:5–6; 2000.
Strandberg, J. D.; Goodman, D. C. Animal model of human disease. Breast cancer. Animal model: canine mammary neoplasia. Am. J. Clin. Pathol. 75:225–228; 1974.
Tsukamoto, A. S.; Grosschedl, R.; Guzman, R. C.; Parslow, T.; Varmus, H. E. Expression of the Wnt-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619–625; 1988.
Wong, S. C. C.; Lo, S. F. E.; Lee, K. C.; Yam, J. W. P.; Chan, J. K. C.; Hsiao, W. L. W. Expression of frizzled-related protein and Wnt-signaling molecules in invasive human breast tumors. J. Pathol. 196:145–153; 2002.
Zhou, Z.; Wang, J.; Han, X.; Zhou, J.; Linder, S. Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors, Int. J. Cancer 78:95–99; 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, JL., Chang, CJ., Chueh, LL. et al. Expression of secreted frizzled-related protein 2 in a primary canine mammary tumor cell line: A candidate tumor marker for mammary tumor cells. In Vitro Cell.Dev.Biol.-Animal 39, 221–227 (2003). https://doi.org/10.1290/1543-706X(2003)039<0221:EOSFPI>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1543-706X(2003)039<0221:EOSFPI>2.0.CO;2